Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Alnylam Pharmaceuticals (ALNY US)
Watchlist
66
Analysis
Health Care
•
United States
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Alnylam Pharmaceuticals
•
17 May 2024 03:00
Alnylam Pharmaceuticals: A Tale Of Continuous Product Growth and Expansion into New Markets! - Major Drivers
Despite the potential subpopulation differences, the management team at Alnylam Pharmaceuticals Inc. reaffirmed their belief that their Alnylam...
Baptista Research
Follow
125 Views
Share
bullish
•
Alnylam Pharmaceuticals
•
24 Feb 2024 16:01
Alnylam Pharmaceuticals: Progress of the HELIOS-B Study & 4 Other Major Drivers
Alnylam Pharmaceuticals reported solid progress across all business areas in 2023, delivering robust product growth for its four wholly-owned...
Baptista Research
Follow
305 Views
Share
bullish
•
Alnylam Pharmaceuticals
•
12 Jan 2024 15:01
Alnylam Pharmaceuticals Inc.: Unlocking Growth with Operational and Margin Excellence! - Major Drivers
Alnylam Pharmaceuticals, Inc. delivered a solid/strong/positive result and managed an all-around beat in the last quarter. The global net product...
Baptista Research
Follow
17 Views
Share
bullish
•
Alnylam Pharmaceuticals
•
18 Sep 2023 14:00
Alnylam Pharmaceuticals Inc.: Can The Latest Collaboration With Roche Be A Game Changer? - Major Drivers
Alnylam Pharmaceuticals, Inc. delivered a disappointing set of results as it was unable to meet the revenue earnings expectations of Wall...
Baptista Research
Follow
230 Views
Share
bearish
•
ImmuneOnco Biopharmaceuticals (Shanghai)
•
14 Jan 2024 09:34
China Healthcare Weekly (Jan.12) - Mainstream R&D Trend, Innovent, BeiGene, Sirnaomics, ImmuneOnco
If we look at mainstream R&D trend, the choices made by companies like Innovent/BeiGene are reasonable. Investment value of Sirnaomics is low....
Xinyao (Criss) Wang
Follow
464 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x